A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease (CHROMA CD)

Trial Identifier:	DRI18450
Sponsor:	Sanofi
Start Date:	June 2025
Primary Completion Date:	December 2026
Study Completion Date:	October 2029
Condition:	Crohn's Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.